Common Contracts

CONFIDENTIAL July 16, 2014 Philip Wagenheim President Zynerba Pharmaceuticals, Inc. 712 Fifth Avenue, 22nd Floor New York, New York 10019

Letter Agreement • June 30th, 2015 • Zynerba Pharmeceuticals, Inc. • Pharmaceutical preparations

• Contract Type
  Letter Agreement
• Filed
  June 30th, 2015
• Company
  Zynerba Pharmeceuticals, Inc.
• Industry
  Pharmaceutical preparations

This letter agreement confirms our understanding regarding the potential waiver by Broadband Capital Management LLC (“BCM”) of Section 7 of that certain Engagement Letter by and between BCM and AllTranz, Inc. (the “Company”) dated March 7, 2014 (the “Engagement Letter”) and attached hereto as Exhibit A. Other than as specified herein, no terms or conditions of the Engagement Letter are otherwise affected hereby.

CONFIDENTIAL July 16, 2014 Philip Wagenheim President Zynerba Pharmaceuticals, Inc. 712 Fifth Avenue, 22nd Floor New York, New York 10019

Letter Agreement • January 12th, 2015 • Zynerba Pharmeceuticals, Inc. • Pharmaceutical preparations

• Contract Type
  Letter Agreement
• Filed
  January 12th, 2015
• Company
  Zynerba Pharmeceuticals, Inc.
• Industry
  Pharmaceutical preparations

This letter agreement confirms our understanding regarding the potential waiver by Broadband Capital Management LLC (“BCM”) of Section 7 of that certain Engagement Letter by and between BCM and AllTranz, Inc. (the “Company”) dated March 7, 2014 (the “Engagement Letter”) and attached hereto as Exhibit A. Other than as specified herein, no terms or conditions of the Engagement Letter are otherwise affected hereby.